Sun Pharma Inds. - Quaterly Results
Date: 22-05-2024
The sales for the March 2024 quarter moved down to Rs. 56391.40 millions as compared to Rs. 59482.20 millions during the year-ago period.The Total Profit for the quarter ended March 2024 of Rs. 8676.00 millions grew from Rs.-10208.20 millionsThe company reported a degrowth in operating Profit to 20124.10 millions from 24809.50 millions.
| | Quarter ended | Year to Date | Year ended |
| | 202403 | 202303 | % Var | 202403 | 202303 | % Var | 202403 | 202303 | % Var |
| Sales | 56391.40 | 59482.20 | -5.20 | 202751.70 | 208121.40 | -2.58 | 202751.70 | 208121.40 | -2.58 |
| Other Income | 1188.80 | 1203.00 | -1.18 | 5534.80 | 3292.90 | 68.08 | 5534.80 | 3292.90 | 68.08 |
| PBIDT | 20124.10 | 24809.50 | -18.89 | 60533.70 | 67518.90 | -10.35 | 60533.70 | 67518.90 | -10.35 |
| Interest | 2175.90 | 1614.50 | 34.77 | 7840.80 | 4721.80 | 66.06 | 7840.80 | 4721.80 | 66.06 |
| PBDT | 17948.20 | -6182.90 | -390.29 | 50502.70 | 33419.20 | 51.12 | 50502.70 | 33419.20 | 51.12 |
| Depreciation | 3930.40 | 4119.80 | -4.60 | 16006.20 | 16008.70 | -0.02 | 16006.20 | 16008.70 | -0.02 |
| PBT | 14017.80 | -10302.70 | -236.06 | 34496.50 | 17410.50 | 98.14 | 34496.50 | 17410.50 | 98.14 |
| TAX | 5341.80 | -94.50 | -5752.70 | 5914.70 | 503.30 | 1075.18 | 5914.70 | 503.30 | 1075.18 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PAT | 8676.00 | -10208.20 | -184.99 | 28581.80 | 16907.20 | 69.05 | 28581.80 | 16907.20 | 69.05 |
| Equity | 2399.30 | 2399.30 | 0.00 | 2399.30 | 2399.30 | 0.00 | 2399.30 | 2399.30 | 0.00 |
| PBIDTM(%) | 35.69 | 41.71 | -14.44 | 29.86 | 32.44 | -7.97 | 29.86 | 32.44 | -7.97 |